Search

Your search keyword '"Haberlova, Jana"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Haberlova, Jana" Remove constraint Author: "Haberlova, Jana"
43 results on '"Haberlova, Jana"'

Search Results

1. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders

2. 2024 update: European consensus statement on gene therapy for spinal muscular atrophy

3. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders

4. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

5. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

7. 2024 update: European consensus statement on gene therapy for spinal muscular atrophy

8. EURO-NMD registry:federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders

11. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

12. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy

16. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy

17. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients

18. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies:a large international cohort

19. Mapping the differences in care for 5,000 Spinal Muscular Atrophy patients, a survey of 24 national registries in North America, Australasia and Europe

20. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy

22. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies

24. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

25. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

26. genetic diagnosis; limb-girdle weakness; neuromuscular disease; next-generation sequencing; targeted exome analysisweakness

27. Response to letter: A decision for life – Treatment decisions in newly diagnosed families with spinal muscular atrophy

28. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

29. Hereditary Spastic Paraplegia 3A Associated With Axonal Neuropathy

30. Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen

31. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

33. Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2

34. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies

35. Loss of function mutations inHARScause a spectrum of inherited peripheral neuropathies

37. Mapping the differences in care for 5,000 Spinal Muscular Atrophy patients, a survey of 24 national registries in North America, Australasia and Europe

38. HomozygousEXOSC3Mutation c.92G→C, p.G31A is a Founder Mutation Causing Severe Pontocerebellar Hypoplasia Type 1 Among the Czech Roma

39. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies.

40. SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve

41. Homozygous EXOSC3 Mutation c.92G→C, p.G31A is a Founder Mutation Causing Severe Pontocerebellar Hypoplasia Type 1 Among the Czech Roma.

42. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies

43. Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2

Catalog

Books, media, physical & digital resources